Policy / Pricing The next FDA commissioner must be a champion for gene therapies BioSpaceThe FDA must provide consistent and predictable regulatory frameworks if the U.S.Gene Therapy PlatformRead full story pharminent June 5, 2026 (Last updated: June 5, 2026) BioSpace The FDA must provide consistent and predictable regulatory frameworks if the U.S. Gene Therapy Platform Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact dataNext: Medicare Advantage in 2026: Enrollment Update and Key Trends Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
